IN2015MN00038A - - Google Patents
Info
- Publication number
- IN2015MN00038A IN2015MN00038A IN38MUN2015A IN2015MN00038A IN 2015MN00038 A IN2015MN00038 A IN 2015MN00038A IN 38MUN2015 A IN38MUN2015 A IN 38MUN2015A IN 2015MN00038 A IN2015MN00038 A IN 2015MN00038A
- Authority
- IN
- India
- Prior art keywords
- formulations
- infection
- anthrax
- vaccine
- antigen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261664062P | 2012-06-25 | 2012-06-25 | |
| US201361801385P | 2013-03-15 | 2013-03-15 | |
| PCT/US2013/047712 WO2014004578A1 (en) | 2012-06-25 | 2013-06-25 | Temperature stable vaccine formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015MN00038A true IN2015MN00038A (de) | 2015-10-16 |
Family
ID=49783811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN38MUN2015 IN2015MN00038A (de) | 2012-06-25 | 2013-06-25 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20150335752A1 (de) |
| EP (1) | EP2863898A4 (de) |
| JP (1) | JP2015525748A (de) |
| KR (1) | KR20150034170A (de) |
| CN (1) | CN104470506A (de) |
| AU (1) | AU2013280480B2 (de) |
| CA (1) | CA2877130A1 (de) |
| HK (1) | HK1207312A1 (de) |
| IL (1) | IL236380A0 (de) |
| IN (1) | IN2015MN00038A (de) |
| RU (1) | RU2014151424A (de) |
| SG (1) | SG11201408262XA (de) |
| WO (1) | WO2014004578A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3086780A4 (de) | 2013-12-27 | 2017-08-09 | Emergent Product Development Gaithersburg Inc. | Temperaturstabile impfstoffformulierungen |
| JP6741580B2 (ja) * | 2013-12-31 | 2020-08-19 | インフェクシャス ディズィーズ リサーチ インスティチュート | 単一バイアルのワクチン製剤 |
| US20170007690A1 (en) * | 2015-07-07 | 2017-01-12 | Nanobio Corporation | Methods and compositions for the stabilization of anthrax recombinant protective antigen |
| US11173197B2 (en) | 2015-07-07 | 2021-11-16 | Bluewillow Biologics, Inc. | Methods and compositions for nanoemulsion vaccine formulations |
| US20170007694A1 (en) * | 2015-07-07 | 2017-01-12 | Nanobio Corporation | Methods and compositions for the stabilization of proteins |
| KR20190053908A (ko) | 2016-09-16 | 2019-05-20 | 로이코케어 아게 | 가공 동안 바이오 의약품의 안정화를 위한 신규한 방법 |
| WO2018050873A1 (en) | 2016-09-16 | 2018-03-22 | Leukocare Ag | A novel method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation |
| KR101744900B1 (ko) | 2017-01-20 | 2017-06-08 | 주식회사 대웅 | 보툴리눔 독소를 포함하는 안정한 액상 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4142095B2 (ja) * | 1994-06-02 | 2008-08-27 | クアドラント・ドラツグ・デリバリー・リミテツド | 各種物質の再水和または融解時の凝集を防止する方法及び該方法により得られる組成物 |
| US7201912B2 (en) * | 2002-04-12 | 2007-04-10 | Emergent Biodefense Operation Lansing Inc. | Recombinant immunogenic compositions and methods for protecting against lethal infections from Bacillus anthracis |
| US9283260B2 (en) * | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
| CN100556400C (zh) * | 2006-07-20 | 2009-11-04 | 上海交通大学 | 载有活性疫苗或抗体的多糖玻璃体微粒的制备方法 |
| WO2008079464A2 (en) * | 2006-09-08 | 2008-07-03 | Becton, Dickinson And Company | Stable powder formulations of alum-adsorbed vaccines |
| EP2829282B1 (de) * | 2007-03-22 | 2017-10-25 | The Regents of The University of Colorado, A Body Corporate | Verfahren zur Herstellung einer immunologisch aktiven, adjuvansgebundenen getrockneten Impfstoffverbindung |
| US8778359B2 (en) * | 2008-07-30 | 2014-07-15 | Emergent Biosolutions Inc. | Stable anthrax vaccine formulations |
| US20110212127A1 (en) * | 2008-09-24 | 2011-09-01 | Stabilitech Ltd. | Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine |
| AU2009338516A1 (en) * | 2009-01-22 | 2011-08-18 | Pharmathene, Inc. | Stable vaccine compositions and methods of use |
-
2013
- 2013-06-25 CN CN201380037918.7A patent/CN104470506A/zh active Pending
- 2013-06-25 KR KR20157000755A patent/KR20150034170A/ko not_active Application Discontinuation
- 2013-06-25 IN IN38MUN2015 patent/IN2015MN00038A/en unknown
- 2013-06-25 US US14/410,942 patent/US20150335752A1/en not_active Abandoned
- 2013-06-25 EP EP13809706.8A patent/EP2863898A4/de not_active Withdrawn
- 2013-06-25 RU RU2014151424A patent/RU2014151424A/ru not_active Application Discontinuation
- 2013-06-25 JP JP2015520412A patent/JP2015525748A/ja not_active Withdrawn
- 2013-06-25 CA CA2877130A patent/CA2877130A1/en not_active Abandoned
- 2013-06-25 AU AU2013280480A patent/AU2013280480B2/en not_active Ceased
- 2013-06-25 WO PCT/US2013/047712 patent/WO2014004578A1/en active Application Filing
- 2013-06-25 SG SG11201408262XA patent/SG11201408262XA/en unknown
-
2014
- 2014-12-21 IL IL236380A patent/IL236380A0/en unknown
-
2015
- 2015-08-19 HK HK15108032.6A patent/HK1207312A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201408262XA (en) | 2015-01-29 |
| EP2863898A1 (de) | 2015-04-29 |
| AU2013280480B2 (en) | 2018-03-15 |
| CA2877130A1 (en) | 2014-01-03 |
| AU2013280480A1 (en) | 2015-01-22 |
| EP2863898A4 (de) | 2016-04-27 |
| IL236380A0 (en) | 2015-02-26 |
| JP2015525748A (ja) | 2015-09-07 |
| HK1207312A1 (en) | 2016-01-29 |
| WO2014004578A1 (en) | 2014-01-03 |
| KR20150034170A (ko) | 2015-04-02 |
| RU2014151424A (ru) | 2016-08-20 |
| CN104470506A (zh) | 2015-03-25 |
| US20150335752A1 (en) | 2015-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015MN00038A (de) | ||
| PH12017502233A1 (en) | Formulations for neoplasia vaccines and methods of preparing thereof | |
| MX2013007657A (es) | Oligodesoxinucleotidos inmunoestimulantes. | |
| MY168959A (en) | Vaccine compositions for the prevention of dengue virus infection | |
| MX2013013800A (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
| PH12014502875A1 (en) | Vaccine compositions for prevention against dengue virus infection | |
| AU2015296298A8 (en) | Flagellin-based agents and uses including effective vaccination | |
| MX2012009581A (es) | Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza. | |
| BR112013003772A2 (pt) | composições de compostos modificadores de resposta imunológica lipidadas, formulações e métodos | |
| LT2811981T (lt) | Pagerintos adjuvanto kompozicijos, apimančios tlr4 agonistus, ir jų panaudojimo būdai | |
| MX2013013801A (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
| IN2015DN02729A (de) | ||
| JO3362B1 (ar) | الحفظ بالتبريد لخلايا سرطان الموت الخلوي المبرمج للاستعمال في العلاج المناعي ضد السرطان | |
| EA201590491A1 (ru) | Иммуногенная композиция | |
| NZ708016A (en) | Lyophilized preparations of melphalan flufenamide | |
| WO2013006569A3 (en) | Herpes virus vaccine and methods of use | |
| NZ630831A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| NZ715459A (en) | A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same | |
| WO2010053610A3 (en) | Stable anthrax vaccine formulations | |
| NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
| IN2015KN00516A (de) | ||
| IL236476A0 (en) | Preparations and methods for the treatment or prevention of infection with the pneumovirus and diseases related to it | |
| EA201491845A1 (ru) | Получение стерильных активных фармацевтических ингредиентов | |
| WO2012078051A3 (en) | IPN Vaccine | |
| CL2015001618A1 (es) | Adyuvante de vacunación, preparación y vacunas que lo contienen |